|Mr. Jeffrey M. Nugent||Chairman & CEO||1.22M||N/A||1947|
|Mr. Patrick F. Williams||Sr. VP, CFO & Treasurer||112.78k||N/A||1973|
|Mr. Charles Huiner||COO and Sr. VP of Corp. Devel. & Strategy||529.38k||N/A||1971|
|Ms. Deborah Bettencourt||VP of Customer Experience & Corp. Admin.||N/A||N/A||N/A|
|Mr. Oliver Bennett||Gen. Counsel and VP of Compliance & Legal||N/A||N/A||N/A|
Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products to plastic surgeons in the United States. It operates through two segments, Breast Products and miraDry. The company offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names. It also provides body contouring products; facial and nasal implants; saline-filled breast implant sizers to identify the correct style and size of implants; and non-breast tissue expanders for expanding tissue and skin surface area for burn care and other reconstructive use. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Santa Barbara, California.
Sientra, Inc.’s ISS Governance QualityScore as of August 1, 2018 is 10. The pillar scores are Audit: 10; Board: 10; Shareholder Rights: 8; Compensation: 9.